Emcure Pharmaceuticals
EMCURE · Pharma > Pharmaceuticals & Drugs Listing date: July 10, 2024

Stock Price vs Company Growth
1d
0.1%
1w
1.4%
1m
6.8%
3m
33.3%
6m
35.7%
all
31.8%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun23Sep23Dec23Jun24Sep24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

927 0.1%
912
1,490
Company Overview

Sales
7,447 Cr
Growth: 18.1%
Profit after Tax
606 Cr
Growth: 2.5%
Mid Cap
17,564 Cr
P/E: 28.4x
Industry P/E: 29.1x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 7,447
Growth 18.1%
EBITDA 18.5%
P/S 2.4x
Dividend 0.0%
P/E 28.4x
Book Value ₹ 10
PEG Ratio 1.6x
ROE 327.2%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep24
Promoters
Created with Highcharts 8.2.2Sep24
Others
Created with Highcharts 8.2.2Sep24
Increase    Decrease    No change
Company Profile Detailed

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Followers (1)